Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
11 June 2021 | Story Rulanzen Martin | Photo Supplied
Prof Joy Owen believes in the mutual intellectual push between research supervisor and student.

Prof Joy Owen, Head of the Department of Anthropology, and two of her students, Ingrid Juries, PhD student and Mamokoena Mokoena, Master’s student, presented a paper exploring the experiences of migrants, at the virtual Oxford Migration Conference that took place from 10 to 11 May 2021 under the theme Borders and Justice.

According to Prof Owen, their paper Bordering on complexity? African migrants’ narratives of boundary creation and dissolution, “tries to make a particular intervention in the transnational migration literature – inclusive of diasporic and refugee studies – which speaks to the complexity of reception in ‘host’ countries”.   Their paper and presentation were included in Routed, a special conference magazine. 

The mainstream portrayal of migrants and residents is that of one-sided aversion and sometimes violence, which gives rise to xenophobic attacks. However, the work done by Prof Owen, Mokoena, and Juries illustrates the ‘rather messy experiences’ of both migrants and citizens and the interpersonal relationships that may result from it.  “These relationships are not merely riddled with negative experiences, but also positive, life-affirming experiences for both migrant and citizen,” says Prof Owen.

 

Xenophobia in South Africa

South Africa in particular, has seen a rise in xenophobic attacks and xenophobia in general, which begs the questions – do we need more research on the matter? Prof Owen says no. “There’s vast literature on xenophobia, and more recently xenophilia – ‘the love of the other’. We need more research that demonstrates the ways in which non-citizens have become part of the South African socio-economic and political fabric,” says Prof Owen.


The complexities of our history in South Africa, that of migration and settlement. “How we narrate those stories, and what we focus on, confirms how we define ourselves as contemporary South Africans, inclusive of migrants in our midst,” says Prof Owen.

 

Mutual intellectual push

For Prof Owen, it is important to reiterate that although Juries and Mokoena are under her supervision, they were also her collaborators for the conference presentation. “Their contemporary knowledge and understanding of the intricate and embattled experiences of migrants in South Africa is growing,” she says. It is a privilege for her to witness the fast, immediate intellectual growth of her students and their academic prowess while being pushed intellectually herself. “That is fundamentally the role of education, is it not? To keep pushing beyond the knowledge we have accrued in service to society,” Prof Owen says. 


News Archive

Stem cell research and human cloning: legal and ethical focal points
2004-07-29

   

(Summary of the inaugural lecture of Prof Hennie Oosthuizen, from the Department of Criminal and Medical Law at the Faculty of Law of the University of the Free State.)

 

In the light of stem cell research, research on embryo’s and human cloning it will be fatal for legal advisors and researchers in South Africa to ignore the benefits that new bio-medical development, through research, contain for this country.

Legal advisors across the world have various views on stem cell research and human cloning. In the USA there is no legislation that regulates stem cell research but a number of States adopted legislation that approves stem cell research. The British Parlement gave permission for research on embryonic stem cells, but determined that it must be monitored closely and the European Union is of the opinion that it will open a door for race purification and commercial exploitation of human beings.

In South Africa the Bill on National Health makes provision for therapeutical and non therapeutical research. It also makes provision for therapeutical embryonical stem cell research on fetuses, which is not older than 14 days, as well as for therapeutical cloning under certain circumstances subject to the approval of the Minister. The Bill prohibits reproductive cloning.

Research on human embrio’s is a very controversial issue, here and in the rest of the world.

Researchers believe that the use of stem cell therapy could help to side-step the rejection of newly transplanted organs and tissue and if a bank for stem cell could be built, the shortage of organs for transplants would become something of the past. Stem cells could also be used for healing of Alzheimer’s, Parkinson’s and spinal injuries.

Sources from which stem cells are obtained could also lead to further ethical issues. Stem cells are harvested from mature human cells and embryonic stem cells. Another source to be utilised is to take egg cells from the ovaries of aborted fetuses. This will be morally unacceptable for those against abortions. Linking a financial incentive to that could become more of a controversial issue because the woman’s decision to abort could be influenced. The ideal would be to rather use human fetus tissue from spontaneous abortions or extra-uterine pregnancies than induced abortions.

The potential to obtain stem cells from the blood of the umbilical cord, bone-marrow and fetus tissue and for these cells to arrange themselves is known for quite some time. Blood from the umbilical cord contains many stem cells, which is the origin of the body’s immune and blood system. It is beneficial to bank the blood of a newborn baby’s umbilical cord. Through stem cell transplants the baby or another family member’s life could be saved from future illnesses such as anemia, leukemia and metabolic storing disabilities as well as certain generic immuno disabilities.

The possibility to withdraw stem cells from human embrio’s and to grow them is more useable because it has more treatment possibilities.

With the birth of Dolly the sheep, communities strongly expressed their concern about the possibility that a new cloning technique such as the replacement of the core of a cell will be used in human reproduction. Embryonic splitting and core replacement are two well known techniques that are associated with the cloning process.

I differentiate between reproductive cloning – to create a cloned human embryo with the aim to bring about a pregnancy of a child that is identical to another individual – and therapeutically cloning – to create a cloned human embryo for research purposes and for healing human illnesses.

Worldwide people are debating whether to proceed with therapeutical cloning. There are people for and against it. The biggest ethical objection against therapeutical cloning is the termination of the development of a potential human being.

Children born from cloning will differ from each other. Factors such as the uterus environment and the environment in which the child is growing up will play a role. Cloning create unique children that will grow up to be unique individuals, just like me and you that will develop into a person, just like you and me. If we understand this scientific fact, most arguments against human cloning will disappear.

Infertility can be treated through in vitro conception. This process does not work for everyone. For some cloning is a revolutionary treatment method because it is the only method that does not require patients to produce sperm and egg cells. The same arguments that were used against in vitro conception in the past are now being used against cloning. It is years later and in vitro cloning is generally applied and accepted by society. I am of the opinion that the same will happen with regard to human cloning.

There is an argument that cloning must be prohibited because it is unsafe. Distorted ideas in this regard were proven wrong. Are these distorted ideas justified to question the safety of cloning and the cloning process you may ask. The answer, according to me, is a definite no. Human cloning does have many advantages. That includes assistance with infertility, prevention of Down Syndrome and recovery from leukemia.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept